Martin P Zeidler
Overview
Explore the profile of Martin P Zeidler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
1187
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Francis S, King T, Zeidler M
Front Med (Lausanne)
. 2024 May;
11:1285772.
PMID: 38698784
JAK/STAT pathway signalling is associated with both chronic inflammatory conditions such as psoriasis and haematological malignancies such as the myeloproliferative neoplasms (MPNs). Here we describe a 73yo female patient with...
2.
Brooks E, Zeidler M, Ong A, Evans I
Front Immunol
. 2024 Jan;
14:1310117.
PMID: 38283366
In blood, plasmatocytes of the haemocyte lineage represent the functional equivalent of vertebrate macrophages and have become an established model with which to study macrophage function and behaviour. However, the...
3.
Mullenger J, Zeidler M, Fragiadaki M
Int J Mol Sci
. 2023 Aug;
24(16).
PMID: 37629022
Ankyrin repeat and single KH domain-containing protein 1 (ANKHD1) is a large, scaffolding protein composed of two stretches of ankyrin repeat domains that mediate protein-protein interactions and a KH domain...
4.
Chen Z, Cordero J, Alqarni A, Slack C, Zeidler M, Bellantuono I
J Gerontol A Biol Sci Med Sci
. 2021 Jun;
77(8):1494-1502.
PMID: 34137822
Over recent decades, increased longevity has not been paralleled by extended health span, resulting in more years spent with multiple diseases in older age. As such, interventions to improve health...
5.
Alqarni A, Zeidler M
Biochem Soc Trans
. 2020 Apr;
48(2):559-567.
PMID: 32239204
Developed over 70 years ago as an anti-folate chemotherapy agent, methotrexate (MTX) is a WHO 'essential medicine' that is now widely employed as a first-line treatment in auto-immune, inflammatory diseases...
6.
Francis S, Thomas S, Luben R, Sousos N, Mead A, Snowden J, et al.
Br J Haematol
. 2019 Sep;
187(3):e69-e72.
PMID: 31525819
No abstract available.
7.
Gremese E, Alivernini S, Tolusso B, Zeidler M, Ferraccioli G
J Leukoc Biol
. 2019 Jul;
106(5):1063-1068.
PMID: 31313387
Methotrexate (MTX) is recognized as the anchor drug in the algorithm treating chronic arthritis (RA, psoriatic arthritis), as well as a steroid sparing agent in other inflammatory conditions (polymyalgia rheumatica,...
8.
Fisher K, Fragiadaki M, Pugazhendhi D, Bausek N, Arredondo M, Thomas S, et al.
J Cell Sci
. 2018 Jun;
131(13).
PMID: 29848658
Cytokine receptors often act via the Janus kinase and signal transducer and activator of transcription (JAK/STAT) pathway to form a signalling cascade that is essential for processes such as haematopoiesis,...
9.
Fragiadaki M, Zeidler M
J Biol Chem
. 2018 Apr;
293(25):9570-9579.
PMID: 29695508
Clear cell renal cell carcinoma (ccRCC) represents the most common kidney cancer worldwide. Increased cell proliferation associated with abnormal microRNA (miRNA) regulation are hallmarks of carcinogenesis. Ankyrin repeat and single...
10.
Chinnaiya K, Lawson M, Thomas S, Haider M, Down J, Chantry A, et al.
Haematologica
. 2017 May;
102(9):e336-e339.
PMID: 28550185
No abstract available.